Please assess the completion status of the following clinical trial:

Trial Title: Efficacy of High Doses Penicillin V Versus High Doses Amoxicillin in the Treatment of Non-severe Pneumonia.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients 18 years to 75 years (inclusive).~* Signs and symptoms of lower respiratory tract infection.~* Radiological confirmation of the diagnosis of pneumonia or not radiological confirmation but the patient has the following symptoms: high fever (\> 38.5 ° C), cough and purulent sputum and auscultation of crackles in a pulmonary focus, the researcher undertakes to confirm after inclusion pneumonia with mandatory radiological study.~* Signature of informed consent.~Exclusion Criteria:~* Impaired consciousness: confused state, delirium, drowsiness, stupor or coma, at the discretion of the investigator~* Respiratory rate\> 30 breaths / minute~* Heart rate\> 125 beats / minute~* Systolic blood pressure \<90 mm ??Hg or diastolic BP \<60 mm Hg~* Hypersensitivity to beta-Lactamics~* O2 saturation \<92%~* Axillary temperature\> 40 ° C~* bronchial Asthma~* Pregnancy or lactation~* Significant comorbidities: renal failure, liver cirrhosis, heart failure, chronic obstructive pulmonary disease, ischemic heart disease diagnosed less than 6 months, stroke diagnosed less than 6 months ago and / or type 1 diabetes mellitus~* Significant alteration in chest radiography: alveolar infiltrates in more than one lobe or bilateral pleural effusion or pulmonary cavitation~* Problems to meet the treatment at home: sociopathy or psychiatric problems, drug and alcohol addiction, or, an unsuitable family environment~* Lack of tolerance to oral therapy: presence of nausea and vomiting, gastrectomy, post-surgery or frank diarrhea~* Immunosuppression: chronic HIV infection, transplant, neutropenic, or, patients receiving immunosuppressive therapy~* active malignancy~* terminal disease~* Hospitalization in the last month~* Taking any systemic antibiotic in the previous three days or a full use of oral antibiotics prior to inclusion in the previous two weeks (use of urinary antiseptics is not a reason for exclusion).~* Difficulty to attend follow-up visits~* Refusal to participate in the study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Penicillin V (Type: EXPERIMENTAL): Penicillin V, 1600000 IU every 8h during 10 days.
- Amoxicillin (Type: ACTIVE_COMPARATOR): Amoxicillin, 1 g every 8h during 10 days.

Based on this trial design, predict the completion outcome and termination type (if applicable).